Zeitschrift für Kardiologie

, Volume 93, Issue 11, pp 855–863 | Cite as

P-selectin in arterial thrombosis

REVIEW

Summary

P-selectin is a transmembrane protein present in the α granules of platelets and the Weibel-Palade bodies of endothelial cells. Following activation, it is rapidly translocated to the cell surface. P-selectin expression in platelets has been shown to be elevated in disorders associated with arterial thrombosis such as coronary artery disease, acute myocardial infarction, stroke, and peripheral artery disease. P-selectin mediates rolling of platelets and leukocytes on activated endothelial cells as well as interactions of platelets with leukocytes. Platelet P-selectin interacts with P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes to form platelet-leukocyte aggregates. Furthermore, this interaction of P-selectin with PSGL-1 induces the upregulation of tissue factor, several cytokines in leukocytes and the production of procoagulant microparticles, thereby contributing to a prothrombotic state. P-selectin is also involved in platelet-platelet interactions, i. e. platelet aggregation which is a major factor in arterial thrombosis. P-selectin interacts with platelet sulfatides, thereby stabilizing initial platelet aggregates formed by GPIIb/IIIa-fibrinogen bridges. Inhibtion of the P-selectin-sulfatide interaction leads to a reversal of platelet aggregation. Thus, P-selectin plays a significant role in platelet aggregation and platelet- leukocyte interactions, both important mechanisms in the development of arterial thrombosis.

Key words

P-selectin platelets arterial thrombosis 

P-Selektin bei arterieller Thrombose

Zusammenfassung

P-Selektin ist ein transmembranöses Protein, das in den α-Granula der Thrombozyten und den Weibel-Palade-Körperchen der Endothelzellen gespeichert ist. Nach Aktivierung dieser Zellen wird es rasch zur Zelloberfläche transportiert. Eine erhöhte Expression von P-Selektin auf Thrombozyten findet sich bei Erkrankungen, die mit arterieller Thrombose einhergehen, wie der koronaren Herzerkrankung, dem akuten Myokardinfarkt, dem Schlaganfall und der peripheren arteriellen Verschlusskrankheit. P-Selektin vermittelt einerseits das Rollen von Thrombozyten und Leukozyten auf aktivierten Endothelzellen, andererseits Interaktionen von Thrombozyten mit Leukozyten. Durch eine Interaktion mit P-Selektin-Glykoprotein-Ligand-1 (PSGL-1) bewirkt thrombozytäres P-Selektin die Bildung von Thrombozyten-Leukozyten-Aggregaten. Diese Interaktion von P-Selektin mit PSGL-1 induziert weiterhin eine vermehrte Produktion von ‘tissue factor’, verschiedenen Zytokinen und prokoagulativen Mikropartikeln in Leukozyten und unterstützt somit einen prothrombotischen Zustand. P-Selektin kommt auch eine Rolle in Thrombozyten-Thrombozyten-Interaktionen zu. Die resultierende Thrombozytenaggregation stellt einen wichtigen Faktor in der arteriellen Thrombose dar. P-Selektin interagiert mit thrombozytären Sulfatiden und stabilisiert so initiale Thrombozytenaggregate, die durch GPIIb/IIIa-Fibrinogen- Brücken vernetzt wurden. Eine Inhibition dieser P-Selektin-Sulfatid-Interaktionen führt zu einer Auflösung von Thrombozytenaggregaten. Somit spielt P-Selektin auch eine wichtige Rolle in der Thrombozyten- und Thrombozyten-Leukozyten-Aggregation—beides wichtige Mechanismen in der Entstehung einer arteriellen Thrombose.

Schlüsselwörter

P-Selektin Thrombozyten Arterielle Thrombose 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Andre P, Hartwell D, Hrachovinova I, Saffaripour S, Wagner DD (2000) Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc Natl Acad Sci USA 97:13835–13840CrossRefPubMedGoogle Scholar
  2. 2.
    Bau J, Gutensohn K, Kuck KH, Beythien C, Stein J, Kuhnl P (2000) Flow-cytometric analysis of platelet activation during rotablation. Z Kardiol 89:15–20CrossRefGoogle Scholar
  3. 3.
    Blankenberg S, Barbaux S, Tiret L (2003) Adhesion molecules and atherosclerosis. Atherosclerosis 170:191–203CrossRefPubMedGoogle Scholar
  4. 4.
    Blann AD, Faragher EB, McCollum CN (1997) Increased soluble P-selectin following myocardial infarction: a new marker for the progression of atherosclerosis. Blood Coagul Fibrinolysis 8:383–390PubMedGoogle Scholar
  5. 5.
    Bonfanti R, Furie BC, Furie B, Wagner DD (1989) PADGEM (GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood 73:1109–1112PubMedGoogle Scholar
  6. 6.
    Buttrum SM, Hatton R, Nash GB (1993) Selectin-mediated rolling of neutrophils on immobilized platelets. Blood 82:1165–1174PubMedGoogle Scholar
  7. 7.
    Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B (1994) P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA 91:8767–8771PubMedGoogle Scholar
  8. 8.
    Cha JK, Jeong MH, Jang JY, Bae HR, Lim YJ, Kim JS, Kim SH, Kim JW (2003) Serial Measurement of Surface Expressions of CD63, P-Selectin and CD40 Ligand on Platelets in Atherosclerotic Ischemic Stroke. A Possible Role of CD40 Ligand on Platelets in Atherosclerotic Ischemic Stroke. Cerebrovasc Dis 16:376–382CrossRefPubMedGoogle Scholar
  9. 9.
    Chen LY, Nichols WW, Hendricks JB, Yang BC, Mehta JL (1994) Monoclonal antibody to P-selectin (PB1.3) protects against myocardial reperfusion injury in the dog. Cardiovasc Res 28:1414–1422PubMedGoogle Scholar
  10. 10.
    Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY (2003) Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 107:3141–3145CrossRefPubMedGoogle Scholar
  11. 11.
    Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA (1996) Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood 88:146–157PubMedGoogle Scholar
  12. 12.
    Downing LJ, Wakefield TW, Strieter RM, Prince MR, Londy FJ, Fowlkes JB, Hulin MS, Kadell AM, Wilke CA, Brown SL, Wrobleski SK, Burdick MD, Anderson DC, Greenfield LJ (1997) Anti-P-selectin antibody decreases inflammation and thrombus formation in venous thrombosis. J Vasc Surg 25:816–828PubMedGoogle Scholar
  13. 13.
    Etzioni A, Frydman M, Pollack S, Avidor I, Phillips ML, Paulson JC, Gershoni-Baruch R (1992) Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med 327:1789–1792PubMedGoogle Scholar
  14. 14.
    Evangelista V, Manarini S, Sideri R, Rotondo S, Martelli N, Piccoli A, Totani L, Piccardoni P, Vestweber D, de Gaetano G, Cerletti C (1999) Platelet/polymorphonuclear leukocyte interaction: P-selectin triggers proteintyrosine phosphorylation-dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood 93:876–885PubMedGoogle Scholar
  15. 15.
    Fox JE (1994) Shedding of adhesion receptors from the surface of activated platelets. Blood Coagul Fibrinolysis 5:291–304PubMedGoogle Scholar
  16. 16.
    Frenette PS, Johnson RC, Hynes RO, Wagner DD (1995) Platelets roll on stimulated endothelium in vivo: an interaction mediated by endothelial P-selectin. Proc Natl Acad Sci USA 92:7450–7454PubMedGoogle Scholar
  17. 17.
    Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD (1996) Susceptibility to infection and altered hematopoiesis in mice deficient in both P- and E-selectins. Cell 84:563–574CrossRefPubMedGoogle Scholar
  18. 18.
    Frenette PS, Denis CV, Weiss L, Jurk K, Subbarao S, Kehrel B, Hartwig JH, Vestweber D, Wagner DD (2000) P-Selectin glycoprotein ligand 1 (PSGL-1) is expressed on platelets and can mediate platelet-endothelial interactions In vivo. J Exp Med 191:1413–1422CrossRefPubMedGoogle Scholar
  19. 19.
    Gawaz M, Neumann FJ, Ott I, May A, Rudiger S, Schomig A (1996) Changes in membrane glycoproteins of circulating platelets after coronary stent implantation. Heart 76:166–172PubMedGoogle Scholar
  20. 20.
    Gurbel PA, Kereiakes DJ, Dalesandro MR, Bahr RD, O’Connor CM, Serebruany VL (2000) Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department. Am Heart J 139:320–328PubMedGoogle Scholar
  21. 21.
    Hayward R, Campbell B, Shin YK, Scalia R, Lefer AM (1999) Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in cats. Cardiovasc Res 41:65–76CrossRefPubMedGoogle Scholar
  22. 22.
    Hollander JE, Muttreja MR, Dalesandro MR, Shofer FS (1999) Risk stratification of emergency department patients with acute coronary syndromes using P-selectin. J Am Coll Cardiol 34:95–105CrossRefPubMedGoogle Scholar
  23. 23.
    Hrachovinova I, Cambien B, Hafezi-Moghadam A, Kappelmayer J, Camphausen RT, Widom A, Xia L, Kazazian HH Jr, Schaub RG, McEver RP, Wagner DD (2003) Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A. Nat Med 9:1020–1025CrossRefPubMedGoogle Scholar
  24. 24.
    Ikeda H, Takajo Y, Ichiki K, Ueno T, Maki S, Noda T, Sugi K, Imaizumi T (1995) Increased soluble form of Pselectin in patients with unstable angina. Circulation 92:1693–1696PubMedGoogle Scholar
  25. 25.
    Ikeda H, Ueyama T, Murohara T, Yasukawa H, Haramaki N, Eguchi H, Katoh A, Takajo Y, Onitsuka I, Ueno T, Tojo SJ, Imaizumi T (1999) Adhesive interaction between P-selectin and sialyl Lewis(x) plays an important role in recurrent coronary arterial thrombosis in dogs. Arterioscler Thromb Vasc Biol 19:1083–1090PubMedGoogle Scholar
  26. 26.
    Isenberg WM, McEver RP, Shuman MA, Bainton DF (1986) Topographic distribution of a granule membrane protein (GMP-140) that is expressed on the platelet surface after activation: an immunogold-surface replica study. Blood Cells 12:191–204PubMedGoogle Scholar
  27. 27.
    Ishiwata N, Takio K, Katayama M, Watanabe K, Titani K, Ikeda Y, Handa M (1994) Alternatively spliced isoform of P-selectin is present in vivo as a soluble molecule. J Biol Chem 269:23708–23715PubMedGoogle Scholar
  28. 28.
    Johnston GI, Cook RG, McEver RP (1989) Cloning of GMP-140, a granule membrane protein of platelets and endothelium: sequence similarity to proteins involved in cell adhesion and inflammation. Cell 56:1033–1044CrossRefPubMedGoogle Scholar
  29. 29.
    Jones DA, Abbassi O, McIntire LV, McEver RP, Smith CW (1993) P-selectin mediates neutrophil rolling on histamine-stimulated endothelial cells. Biophys J 65:1560–1569PubMedGoogle Scholar
  30. 30.
    Klinkhardt U, Graff J, Harder S (2002) Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clin Pharmacol Ther 71:176–185CrossRefPubMedGoogle Scholar
  31. 31.
    Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S (2003) Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 73:232–241CrossRefPubMedGoogle Scholar
  32. 32.
    Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG (1999) Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model. Circulation 99:1363–1369PubMedGoogle Scholar
  33. 33.
    Larsen E, Celi A, Gilbert GE, Furie BC, Erban JK, Bonfanti R, Wagner DD, Furie B (1989) PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell 59:305–312CrossRefPubMedGoogle Scholar
  34. 34.
    Lehr HA, Olofsson AM, Carew TE, Vajkoczy P, von Andrian UH, Hubner C, Berndt MC, Steinberg D, Messmer K, Arfors KE (1994) P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest 71:380–386PubMedGoogle Scholar
  35. 35.
    Li F, Erickson HP, James JA, Moore KL, Cummings RD, McEver RP (1996) Visualization of P-selectin glycoprotein ligand-1 as a highly extended molecule and mapping of protein epitopes for monoclonal antibodies. J Biol Chem 271:6342–6348CrossRefPubMedGoogle Scholar
  36. 36.
    Mayadas TN, Johnson RC, Rayburn H, Hynes RO, Wagner DD (1993) Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell 74:541–554PubMedGoogle Scholar
  37. 37.
    Merten M, Pakala R, Thiagarajan P, Benedict CR (1999) Platelet microparticles promote platelet interaction with subendothelial matrix in a glycoprotein IIb/IIIa-dependent mechanism. Circulation 99:2577–2582PubMedGoogle Scholar
  38. 38.
    Merten M, Thiagarajan P (2000) P-selectin expression on platelets determines size and stability of platelet aggregates. Circulation 102:1931–1936PubMedGoogle Scholar
  39. 39.
    Merten M, Chow T, Hellums JD, Thiagarajan P (2000) A New Role for P-selectin in Shear-induced Platelet Aggregation. Circulation 102:2045–2050PubMedGoogle Scholar
  40. 40.
    Merten M, Thiagarajan P (2001) Role for Sulfatides in Platelet Aggregation. Circulation 104:2955–2960PubMedGoogle Scholar
  41. 41.
    Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI (2001) Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 104:1533–1537PubMedGoogle Scholar
  42. 42.
    Molenaar TJ, Twisk J, de Haas SA, Peterse N, Vogelaar BJ, van Leeuwen SH, Michon IN, van Berkel TJ, Kuiper J, Biessen EA (2003) P-selectin as a candidate target in atherosclerosis. Biochem Pharmacol 66:859–866CrossRefPubMedGoogle Scholar
  43. 43.
    Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ (2000) Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 36:699–705CrossRefPubMedGoogle Scholar
  44. 44.
    Mulligan MS, Paulson JC, De Frees S, Zheng ZL, Lowe JB, Ward PA (1993) Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature 364:149–151CrossRefPubMedGoogle Scholar
  45. 45.
    Mulligan MS, Warner RL, Lowe JB, Smith PL, Suzuki Y, Miyasaka M, Yamaguchi S, Ohta Y, Tsukada Y, Kiso M, Hasegawa A, Ward PA (1998) In vitro and in vivo selectin-blocking activities of sulfated lipids and sulfated sialyl compounds. Int Immunol 10:569–575CrossRefPubMedGoogle Scholar
  46. 46.
    Murphy RT, Foley JB, Mulvihill N, Crean P, Walsh MJ (2001) Impact of preexisting statin use on adhesion molecule expression in patients presenting with acute coronary syndromes. Am J Cardiol 87:446–448CrossRefPubMedGoogle Scholar
  47. 47.
    Norgard KE, Moore KL, Diaz S, Stults NL, Ushiyama S, McEver RP, Cummings RD, Varki A (1993) Characterization of a specific ligand for P-selection on myeloid cells. A minor glycoprotein with sialylated O-linked oligosaccharides. J Biol Chem 268:12764–12774PubMedGoogle Scholar
  48. 48.
    O’Connor CM, Gurbel PA, Serebruany VL (1999) Usefulness of soluble and surface-bound P-selectin in detecting heightened platelet activity in patients with congestive heart failure. Am J Cardiol 83:1345–1349CrossRefPubMedGoogle Scholar
  49. 49.
    Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, Sajer SA, Furie B (1992) Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature 359:848–851CrossRefPubMedGoogle Scholar
  50. 50.
    Pouyani T, Seed B (1995) PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus. Cell 83:333–343CrossRefPubMedGoogle Scholar
  51. 51.
    Ridker PM, Buring JE, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103:491–495PubMedGoogle Scholar
  52. 52.
    Romo GM, Dong JF, Schade AJ, Gardiner EE, Kansas GS, Li CQ, McIntire LV, Berndt MC, Lopez JA (1999) The glycoprotein Ib-IX-V complex is a platelet counterreceptor for P-selectin. J Exp Med 190:803–814CrossRefPubMedGoogle Scholar
  53. 53.
    Rupprecht HJ, Darius H, Borkowski U, Voigtlander T, Nowak B, Genth S, Meyer J (1998) Comparison of anti-platelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 97:1046–1052PubMedGoogle Scholar
  54. 54.
    Sharar SR, Sasaki SS, Flaherty LC, Paulson JC, Harlan JM, Winn RK (1993) P-selectin blockade does not impair leukocyte host defense against bacterial peritonitis and soft tissue infection in rabbits. J Immunol 151:4982–4988PubMedGoogle Scholar
  55. 55.
    Subramaniam M, Frenette PS, Saffaripour S, Johnson RC, Hynes RO, Wagner DD (1996) Defects in hemostasis in P-selectin-deficient mice. Blood 87:1238–1242PubMedGoogle Scholar
  56. 56.
    Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF (1985) A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 101:880–886CrossRefPubMedGoogle Scholar
  57. 57.
    Toombs CF, DeGraaf GL, Martin JP, Geng JG, Anderson DC, Shebuski RJ (1995) Pretreatment with a blocking monoclonal antibody to P-selectin accelerates pharmacological thrombolysis in a primate model of arterial thrombosis. J Pharmacol Exp Ther 275:941–949PubMedGoogle Scholar
  58. 58.
    Tregouet DA, Barbaux S, Escolano S, Tahri N, Golmard JL, Tiret L, Cambien F (2002) Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11:2015–2023CrossRefPubMedGoogle Scholar
  59. 59.
    Yang J, Hirata T, Croce K, Merrill-Skoloff G, Tchernychev B, Williams E, Flaumenhaft R, Furie BC, Furie B (1999) Targeted gene disruption demonstrates that P-selectin glycoprotein ligand 1 (PSGL-1) is required for P-selectin-mediated but not E-selectin-mediated neutrophil rolling and migration. J Exp Med 190:1769–1782CrossRefPubMedGoogle Scholar
  60. 60.
    Zeiger F, Stephan S, Hoheisel G, Pfeiffer D, Ruehlmann C, Koksch M (2000) P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease. Blood Coagul Fibrinolysis 11:723–728CrossRefPubMedGoogle Scholar

Copyright information

© Steinkopff Verlag 2004

Authors and Affiliations

  1. 1.Herzzentrum, Medizinische Klinik III, Kardiologie und AngiologieUniversitätsklinik Hamburg-EppendorfHamburgGermany
  2. 2.Department of Pathology and MedicineBaylor College of Medicine, VAMC #113Houston TX77030USA

Personalised recommendations